Skip to main content
Premium Trial:

Request an Annual Quote

Illumina's Q2 Revenue, R&D Spending More Than Double as Profit Jumps 37 Percent

NEW YORK (GenomeWeb News) — Illumina yesterday said second-quarter revenues and R&D spending more than doubled over last year as profits jumped 37 percent.
 
Total receipts for the three months ended June 30 increased to $84.5 million from $41.6 million year over year.
 
Product revenues jumped to $74.3 million from $36.4 million, while service and other revenue increased to $10.1 million from $4.8 million year over year.
 
R&D spending swelled to $18.2 million from $8.6 million in the year-ago period.
 
Profit for the second quarter increased to $9.3 million from $6.8 million.
 
llumina said it had around $343 million in cash, equivalents, and short-term investments as of June 30.
 
The company raised its expected full-year 2007 revenue to between $335 million and $345 million, which is $30 million higher than projections it made in April and as much as 86 percent better than 2006 receipts.
 
Third-quarter revenues are expected to be between $88 million and $92 million, or as much as 74 percent over the same period last year. 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.